Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 7 | 2026 | 96 | 3.880 |
Why?
|
| Neoplastic Stem Cells | 5 | 2026 | 99 | 3.050 |
Why?
|
| Brain Neoplasms | 6 | 2026 | 140 | 2.860 |
Why?
|
| Glioblastoma | 4 | 2026 | 74 | 2.610 |
Why?
|
| STAT3 Transcription Factor | 6 | 2024 | 102 | 2.050 |
Why?
|
| TRPM Cation Channels | 3 | 2023 | 40 | 1.920 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2025 | 83 | 1.720 |
Why?
|
| Signal Transduction | 6 | 2026 | 2157 | 1.650 |
Why?
|
| Receptors, Notch | 2 | 2025 | 38 | 1.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2026 | 968 | 1.120 |
Why?
|
| Oncogenes | 2 | 2025 | 44 | 1.110 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2026 | 3 | 0.970 |
Why?
|
| Transcriptional Activation | 2 | 2025 | 173 | 0.970 |
Why?
|
| Receptor, Notch1 | 1 | 2026 | 16 | 0.960 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2026 | 33 | 0.960 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2025 | 23 | 0.920 |
Why?
|
| Ubiquitination | 1 | 2025 | 62 | 0.900 |
Why?
|
| Promoter Regions, Genetic | 3 | 2024 | 526 | 0.880 |
Why?
|
| NF-kappa B | 1 | 2024 | 358 | 0.690 |
Why?
|
| Cell Line, Tumor | 6 | 2026 | 2676 | 0.660 |
Why?
|
| Cell Proliferation | 4 | 2026 | 1455 | 0.560 |
Why?
|
| Malaria, Cerebral | 1 | 2018 | 30 | 0.550 |
Why?
|
| Neuregulin-1 | 1 | 2018 | 26 | 0.550 |
Why?
|
| Newcastle disease virus | 1 | 2017 | 1 | 0.530 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2017 | 72 | 0.500 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 299 | 0.480 |
Why?
|
| MicroRNAs | 1 | 2022 | 518 | 0.470 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2013 | 16 | 0.410 |
Why?
|
| Heme | 1 | 2013 | 72 | 0.390 |
Why?
|
| Apoptosis | 3 | 2018 | 1568 | 0.360 |
Why?
|
| Cell Division | 1 | 2012 | 311 | 0.360 |
Why?
|
| Interleukin-6 | 1 | 2012 | 165 | 0.360 |
Why?
|
| Receptors, CXCR3 | 1 | 2011 | 31 | 0.350 |
Why?
|
| Chemokine CXCL10 | 1 | 2011 | 38 | 0.350 |
Why?
|
| Humans | 11 | 2026 | 43102 | 0.330 |
Why?
|
| Neoplasm Proteins | 1 | 2012 | 228 | 0.330 |
Why?
|
| Endothelial Cells | 1 | 2013 | 329 | 0.320 |
Why?
|
| Animals | 6 | 2026 | 16992 | 0.310 |
Why?
|
| Mice | 3 | 2026 | 6644 | 0.270 |
Why?
|
| Ribonucleoproteins | 1 | 2025 | 31 | 0.230 |
Why?
|
| Mice, Nude | 1 | 2026 | 408 | 0.220 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2024 | 11 | 0.210 |
Why?
|
| Transcription Factor RelA | 1 | 2024 | 42 | 0.210 |
Why?
|
| Biological Assay | 1 | 2023 | 63 | 0.200 |
Why?
|
| Base Sequence | 2 | 2014 | 983 | 0.180 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 1542 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1723 | 0.170 |
Why?
|
| Protein Binding | 2 | 2014 | 1082 | 0.160 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 436 | 0.150 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1271 | 0.150 |
Why?
|
| Hemangioendothelioma | 1 | 2018 | 2 | 0.140 |
Why?
|
| Coculture Techniques | 1 | 2018 | 109 | 0.140 |
Why?
|
| Brain | 1 | 2023 | 1472 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1124 | 0.110 |
Why?
|
| Phosphotyrosine | 1 | 2014 | 23 | 0.110 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 10 | 0.110 |
Why?
|
| Epithelial Cells | 1 | 2018 | 434 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 77 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 196 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2014 | 168 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1621 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 189 | 0.100 |
Why?
|
| Janus Kinases | 1 | 2013 | 23 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 290 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 1869 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 1596 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2012 | 69 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2014 | 536 | 0.090 |
Why?
|
| Binding Sites | 1 | 2013 | 671 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 183 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2011 | 68 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2011 | 62 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 652 | 0.080 |
Why?
|
| Models, Biological | 1 | 2014 | 712 | 0.080 |
Why?
|
| Estradiol | 1 | 2012 | 268 | 0.080 |
Why?
|
| Cell Movement | 1 | 2014 | 655 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2013 | 986 | 0.080 |
Why?
|
| Female | 2 | 2026 | 24698 | 0.080 |
Why?
|
| Cell Line | 1 | 2013 | 1410 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 704 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 719 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1070 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 758 | 0.060 |
Why?
|